Parallel Advisors, LLC Dexcom Inc Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,977 shares of DXCM stock, worth $147,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,977

Previous 4,024 50.87%

Holding current value

$147,642

Previous $456,000 71.05%

% of portfolio

0.0%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $131,008 - $237,574	-2,047 Reduced 50.87%	1,977 $132,000
Q2 2024 Aug 08, 2024	SELL	$110.31 - $140.45 $11,913 - $15,168	-108 Reduced 2.61%	4,024 $456,000
Q1 2024 May 06, 2024	BUY	$114.22 - $140.1 $59,965 - $73,552	525 Added 14.56%	4,132 $573,000
Q4 2023 Feb 09, 2024	BUY	$75.49 - $124.16 $89,757 - $147,626	1,189 Added 49.17%	3,607 $447,000
Q3 2023 May 20, 2024	SELL	$86.06 - $137.93 $34,079 - $54,620	-396 Reduced 14.07%	2,418 $225,000
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $34,079 - $54,620	-396 Reduced 14.07%	2,418 $225,000
Q2 2023 May 20, 2024	BUY	$112.47 - $130.98 $7,310 - $8,513	65 Added 2.36%	2,814 $361,000
Q2 2023 Aug 04, 2023	BUY	$112.47 - $130.98 $7,310 - $8,513	65 Added 2.36%	2,814 $361,000
Q1 2023 May 20, 2024	SELL	$104.0 - $122.92 $143,832 - $169,998	-1,383 Reduced 33.47%	2,749 $319,000
Q1 2023 Apr 25, 2023	SELL	$104.0 - $122.92 $39,312 - $46,463	-378 Reduced 12.09%	2,749 $319,000
Q4 2022 Feb 03, 2023	BUY	$84.98 - $122.67 $64,924 - $93,719	764 Added 32.33%	3,127 $354,000
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $51,841 - $63,948	679 Added 40.32%	2,363 $190,000
Q2 2022 Aug 01, 2022	BUY	$67.99 - $132.89 $74,585 - $145,780	1,097 Added 186.88%	1,684 $126,000
Q1 2022 Apr 28, 2022	SELL	$94.08 - $130.2 $1,317 - $1,822	-14 Reduced 2.33%	587 $305,000
Q4 2021 Jan 20, 2022	BUY	$129.87 - $162.82 $3,246 - $4,070	25 Added 4.34%	601 $323,000
Q3 2021 Nov 02, 2021	BUY	$106.71 - $143.18 $15,046 - $20,188	141 Added 32.41%	576 $315,000
Q2 2021 Aug 06, 2021	BUY	$80.99 - $107.93 $7,046 - $9,389	87 Added 25.0%	435 $186,000
Q1 2021 Apr 23, 2021	SELL	$84.79 - $104.74 $10,005 - $12,359	-118 Reduced 25.32%	348 $125,000
Q4 2020 Feb 02, 2021	SELL	$78.0 - $104.5 $18,642 - $24,975	-239 Reduced 33.9%	466 $172,000
Q3 2020 Oct 27, 2020	BUY	$95.51 - $112.95 $37,821 - $44,728	396 Added 128.16%	705 $291,000
Q2 2020 Jul 16, 2020	SELL	$62.68 - $105.34 $2,256 - $3,792	-36 Reduced 10.43%	309 $125,000
Q1 2020 Apr 27, 2020	SELL	$47.79 - $75.63 $1,338 - $2,117	-28 Reduced 7.51%	345 $92,000
Q4 2019 Jan 30, 2020	BUY	$36.62 - $57.29 $4,833 - $7,562	132 Added 54.77%	373 $82,000
Q3 2019 Nov 01, 2019	BUY	$35.53 - $43.8 $1,065 - $1,314	30 Added 14.22%	241 $36,000
Q2 2018 Jul 30, 2018	BUY	$17.54 - $25.22 $1,280 - $1,841	73 Added 52.9%	211 $20,000
Q1 2018 May 08, 2018	BUY	$13.06 - $18.54 $352 - $500	27 Added 24.32%	138 $10,000
Q3 2017 Nov 15, 2017	BUY	$11.36 - $18.98 $1,260 - $2,106	111 New	111 $6,000
Q3 2017 Nov 14, 2017	SELL	$11.36 - $18.98 $1,113 - $1,860	-98 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	98	98 $7,000

Others Institutions Holding DXCM

# of Institutions

1,015

Shares Held

349M

Call Options Held

5.66M

Put Options Held

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Dexcom Inc Transaction History